Connect with us

Science

Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs

Published

on

Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs

The Trump administration on Friday rejected a Biden plan that would have required Medicare and Medicaid to cover obesity drugs and expanded access for millions of people.

Under the law that established Medicare’s Part D drug benefits, the program was forbidden from paying for drugs for “weight loss.” But the Biden administration’s proposal last November had attempted to sidestep that ban by arguing that the drugs would be allowed to treat the disease of obesity and its related conditions.

Expanding coverage of the drugs would have cost the federal government billions of dollars. The Congressional Budget Office estimated the federal expense would amount to about $35 billion over 10 years.

The decision announced Friday was part of a larger 438-page regulation updating parts of Medicare’s Part D drug benefits and Medicare Advantage, the private insurance plans that about half of Medicare beneficiaries now use.

Catherine Howden, a spokeswoman for the Centers for Medicare and Medicaid Services, said in an email that the agency believed that expanding coverage “is not appropriate at this time.” But she said the agency had not ruled out coverage and “may consider future policy options” for the drugs.

Advertisement

Medicare, the government insurance program for Americans over 65 and people with disabilities, does cover the weight-loss drugs for patients with diabetes, and for a much smaller subset of people who are obese and also have heart problems or sleep apnea.

The Biden plan would have extended coverage to patients who were obese but did not have those diseases. Medicare officials had estimated around 3.4 million more people would have chosen to take the drugs under the policy.

The most popular weight-loss drugs are made by Novo Nordisk, which sells its medicine as Wegovy for obesity and as Ozempic for diabetes, and by Eli Lilly, which sells its product as Zepbound for obesity and Mounjaro for diabetes.

Eli Lilly and Novo Nordisk now offer their products for $350 to $500 a month to patients who pay with their own money instead of going through insurance. But until recently, patients sometimes paid more than $1,300 a month.

Robert F. Kennedy Jr., the health secretary, has been vocal in his criticism of the weight-loss drugs, saying they are inferior to consuming healthy food.

Advertisement

The drugs have been shown in clinical trials to have benefits far beyond weight loss, like preventing heart attacks and strokes.

Proponents of expanded coverage have argued that the government’s expenditure on the drugs would at least partly pay for itself in the long run. Patients, they say, would become healthier and that would prevent expensive medical bills. It’s not clear yet whether such savings will materialize.

State Medicaid programs, which provide health care for the poor, can currently choose whether to cover the drugs, and some do. If the broader Biden policy had been finalized, coverage would have been required in every state.

The obesity drugs cost Medicare and Medicaid hundreds of dollars per patient each month, though the exact prices are secret.

Many employers and private health insurance plans do not cover the drugs. Some, including state employee benefit plans in North Carolina and West Virginia, dropped coverage of the drugs after their popularity surged, citing high costs.

Advertisement

Without insurance coverage, many patients on Medicare and Medicaid have been relying on inexpensive copycat versions of the drugs produced through a drug-ingredient mixing process known as compounding. These versions, which were allowed because the brand-name drugs were in short supply, can cost less than $200 a month. But regulators have ordered such sales to end soon because supply of the brand-name products has improved.

Republicans in Congress have expressed some interest in requiring Medicare to cover the drugs. The idea was included in a list of policy options produced by the House Budget Committee earlier this year. But it does not appear to be a major priority right now.

In an effort to reduce costs, Medicare has selected Novo Nordisk’s Wegovy for negotiations to lower prices under a law passed by a Democratic-controlled Congress in 2022. Those lower prices would kick in for eligible people in 2027, a change that has the potential to limit the long-term costs of coverage.

Science

NASA launches humans to moon for first time in half-century

Published

on

NASA launches humans to moon for first time in half-century

For the first time in more than 50 years, astronauts are on their way to the moon.

NASA’s colossal Space Launch System rocket lifted off at 3:35 p.m. Pacific time from the Kennedy Space Center in Florida, marking the start of the 10-day Artemis II mission.

In the hours and minutes leading up to launch, as the astronauts waited aboard, NASA engineers troubleshooted minor issues with the 30-story-tall rocket. First, the teams identified an issue with the hardware that communicates with a system designed to detonate the rocket to protect public safety if the rocket veers off course. Next, there was a fluke temperature reading on the Launch Abort System, designed to pull the crew to safety during such an event. Finally, they managed a brief telemetry issue with the capsule.

All were ultimately resolved, and the agency proceeded.

“On this historic mission, you take with you the heart of this Artemis team, the daring spirit of the American people and our partners across the globe, and the hopes and dreams of a new generation,” Artemis II launch director Charlie Blackwell-Thompson said to the crew minutes before launch. “Good luck. Godspeed, Artemis II. Let’s go.”

Advertisement

In a few days’ time, the four astronauts aboard will perform a flyby of the moon — they will not land on the surface nor will they enter the moon’s orbit. Instead, the flyby is designed as an essential stepping-stone mission to test the rocket, human life support systems and flight procedures ahead of a lunar landing, which NASA hopes to pull off in 2028.

NASA’s Artemis II moon rocket lifts off from the Kennedy Space Center on Wednesday in Cape Canaveral, Fla.

(Joe Raedle / Getty Images)

This includes studies on the astronauts’ sleep and mental health, as well as how deep-space radiation and microgravity affect organs and immune system. The crew will also practice manually piloting the spacecraft while still close to Earth.

Advertisement

NASA expects the crew to reach the moon Monday morning, around 10 a.m. Pacific time. As the astronauts pass the far side of the moon, NASA expects to temporarily lose communication with the crew, who will focus on documenting and analyzing the rugged lunar surface. Around this point, NASA anticipates the crew will break the Apollo 13 crew’s record for the farthest distance any human has traveled from Earth.

The crew will then begin their four-day return. The crew capsule is set to slam into the Earth’s atmosphere at roughly 30 times the speed of sound — potentially making it the fastest reentry of a crewed capsule in history — on April 10. NASA anticipates the crew will splash down off the coast of San Diego around 5 p.m. Pacific time.

The mission, made possible by scientists, engineers and support crews across the country and world, has a touch of Southern California, too.

Victor Glover, the astronaut piloting the mission, was once a kid in the Pomona Valley, watching the space shuttle launch on TV and dreaming of driving the thing. He cut his teeth as a test pilot out in the Mojave, attending test pilot school at Edwards Air Force Base and serving on a Navy test pilot squadron in China Lake, Calif.

If the mission is successful, Glover will become the first Black person to travel to the moon. With him will be the first woman to do so, NASA astronaut Christina Koch, and the first non-American to do so, Jeremy Hansen of the Canadian Space Agency. Not to be outdone by his crewmates, mission commander Reid Wiseman, at 50, will be the oldest to do so.

Advertisement

NASA’s Armstrong Flight Research Center inside Edwards Air Force Base is also conducting critical research and testing for the mission. They supported two tests of the rocket’s Launch Abort System — designed to accelerate from 0 to 500 mph in just two seconds to literally outrun the debris of an exploding rocket — in the 2010s. (The rocket discarded the abort system after the crew safely escaped the majority of Earth’s atmosphere.)

During reentry, the center will participate in a high-speed relay of military and civilian planes to chase the capsule and measure how the heat shield performs with high-tech telescopes and sensors. Artemis II is testing out a new reentry trajectory after an uncrewed test mission in 2022 resulted in unexpected damage to the heat shield.

Finally, once the capsule safely splashes down off San Diego, NASA and U.S. Navy divers will secure the capsule, with medical staff from both on standby. A Navy ship will then bring the capsule back to Naval Base San Diego, right next to the city’s downtown.

The Artemis program ultimately aims to land humans back on the moon, help the space agency establish a lunar base and serve as the testing grounds for future missions to Mars.

NASA plans to launch Artemis III, a mission in Earth’s orbit to test docking the NASA spacecraft with SpaceX’s and Blue Origin’s lunar landers, in 2027. It aspires to launch Artemis IV, which would put humans on the surface of the moon, in 2028.

Advertisement

“Artemis II is the opening act,” said NASA Administrator Jared Isaacman shortly before launch. “We’re going into the golden age of science and discovery right now.”

Continue Reading

Science

NASA will attempt to launch astronauts to the moon today. What to know and how to watch

Published

on

NASA will attempt to launch astronauts to the moon today. What to know and how to watch

On Wednesday, for the first time since 1972, NASA is attempting to launch astronauts to the moon.

The space agency is targeting a 3:24 p.m. Pacific time launch of the colossal Space Launch System rocket with four astronauts aboard. Once off the ground, the crew — including Southern California native Victor Glover — will fly past the moon (but not land on the lunar surface or enter its orbit) and splash down off the coast of San Diego in roughly 10 days.

How to watch

NASA has already begun around-the-clock coverage of the entire mission — including launch preparations, liftoff, the lunar flyby and splashdown — on its YouTube page.

NASA is also livestreaming major milestones, including the launch, on its X account, Facebook page, Twitch profile and website.

If cable television is more your speed, C-SPAN is covering the launch (featuring its famous viewer calls).

Advertisement

Backup dates

The launch is ultimately dependent on the weather. The forecast shows an 80% chance of favorable weather for launch, with some potential for clouds and high winds at ground level that could delay the mission. Wednesday’s launch opportunity is open for two hours, until 5:24 p.m.

If weather or minor technical concerns prevent launch Wednesday, NASA has additional two-hour launch windows every evening through April 6. After that, it would have to wait until at least April 30.

The historical significance

Artemis II is the first mission since Apollo 17 in 1972 to carry humans to the moon. The capsule will carry the first Black person, first woman and first non-American to travel around the moon — potentially traveling farther and reentering the Earth’s atmosphere faster than any other human mission in history.

Although the astronauts will not land on the moon, Artemis II mimics early Apollo missions that were designed as a stepping stone to test all of the equipment and procedures before making the daring landing.

A springboard to Mars

The Artemis program ultimately aims to land humans back on the moon, help the space agency establish a lunar base and serve as the testing grounds for future missions to Mars.

Advertisement

NASA plans to launch Artemis III, a mission in Earth’s orbit to test docking the NASA spacecraft with SpaceX’s and Blue Origin’s lunar landers, in 2027. It aspires to launch Artemis IV, which would put humans on the surface of the moon, in 2028.

Continue Reading

Science

Video: NASA’s Mission Back to the Moon

Published

on

Video: NASA’s Mission Back to the Moon
Artemis II, which would be the first time anyone would travel this far from Earth since 1972, launches on April 1. Kenneth Chang, a reporter for The New York Times, describes how the mission is key to a U.S. goal.

By Kenneth Chang, Marco Hernandez, Melanie Bencosme, Jon Miller, Gabriel Blanco, Joey Sendaydiego and Luke Piotrowski

April 1, 2026

Continue Reading

Trending